Lombard Odier Asset Management (USA)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,000
| Closed | -$366K | – | 186 |
|
|
2020
Q2 | $366K | Hold |
3,000
| – | – | 0.03% | 148 |
|
|
2020
Q1 | $260K | Buy |
+3,000
| New | +$260K | 0.03% | 132 |
|
|
2016
Q3 | – | Sell |
-30,755
| Closed | -$1.4M | – | 231 |
|
|
2016
Q2 | $1.4M | Buy |
30,755
+5,914
| +24% | +$269K | 0.17% | 117 |
|
|
2016
Q1 | $982K | Buy |
+24,841
| New | +$982K | 0.13% | 131 |
|